Condition
Hyperglycemia, Postprandial
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 7 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownDiabetes Risk in London and Its Association with Vitamin D by Ethnic Group (DELVE)NCT06241976 · 2023-07-01
COMPLETEDEffect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy AdultsNCT04730882 · 2021-04-06
COMPLETEDAlleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial PancreasNCT04163874 · 2020-02-14
COMPLETEDGlucagon Response to Prandial Insulin Administration in Persons With Type 1 DiabetesNCT04079881 · 2020-02-13
TERMINATEDKetone Supplementation, Glucose Control, and Cardiovascular FunctionNCT03817749 · 2019-02-06
COMPLETEDEffect of Protein Intake on Post Prandial Hyperglycemia in Children and Adolescents With Type1 Diabetes MellitusNCT04655131 · 2018-06-18
COMPLETEDExercise-meal Timing and Postprandial Glucose ControlNCT03730727 · 2017-10-09
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED6
TERMINATED1
Phase mix
NA5
PHASE11
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.